Dual Antiplatelet Therapy Following Coronary Stent Implantation Associated With Significant Improvement

Dual Antiplatelet Therapy Following Coronary Stent Implantation Associated With Significant Improvement

FDA Approval of the Zilver PTX Drug-Eluting Stent: An Interview with Gary M. Ansel, MD | Vascular Disease Management

FDA Approval of the Zilver PTX Drug-Eluting Stent: An Interview with Gary M. Ansel, MD | Vascular Disease Management

Coronary Drug-Eluting Stent: Products, Design Features, Indications

Coronary Drug-Eluting Stent: Products, Design Features, Indications

Last week Abbott had sought permission to withdraw its ‘alpine drug eluting’ stent and ‘absorb dissolving’ stent, while Medtronic had also sought to withdraw its Onyx Zotarolimus eluting stents. Photo: Reuters

Last week Abbott had sought permission to withdraw its ‘alpine drug eluting’ stent and ‘absorb dissolving’ stent, while Medtronic had also sought to withdraw its Onyx Zotarolimus eluting stents. Photo: Reuters

Pyrogen Testing Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Pyrogen Testing Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Precision Medicine Market – Global Industry Analysis, Size, Share, Growth Trends and Forecast, 2016 - 2024

Drug-eluting stents: Do they increase heart attack risk?

Drug-eluting stents: Do they increase heart attack risk?

Cook Medical is First to Win FDA Approval of Drug-Eluting Stent     11/16/2012 8:23:44 AM    Cook Medical has received FDA approval for the first drug-eluting stent to treat peripheral artery disease in the U.S. The Zilver PTX Drug-Eluting Peripheral Stent is a self-expanding metal stent coated with the drug paclitaxel to help prevent recurring narrowing of the artery. Drug-eluting stents are currently approved for use in coronary arteries in heart attack patients.

Cook Medical is First to Win FDA Approval of Drug-Eluting Stent 11/16/2012 8:23:44 AM Cook Medical has received FDA approval for the first drug-eluting stent to treat peripheral artery disease in the U.S. The Zilver PTX Drug-Eluting Peripheral Stent is a self-expanding metal stent coated with the drug paclitaxel to help prevent recurring narrowing of the artery. Drug-eluting stents are currently approved for use in coronary arteries in heart attack patients.

Get Sample at:https://www.marketreportsworld.com/enquiry/request-sample/10373502  This report studies Drug Eluting Stents (DES) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

Get Sample at:https://www.marketreportsworld.com/enquiry/request-sample/10373502 This report studies Drug Eluting Stents (DES) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

Pinterest
Search